Estrella Immunopharma's total assets for Q0 0 were $3.74M, a decrease of -16.14% from the previous quarter. ESLA total liabilities were $2.99M for the fiscal quarter, a 1554.04% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.